This research explores factors that influence variability in patient response to drug therapies during clinical trials. Biological, demographic, and clinical variables are examined to better understand why patients may respond differently to the same treatment.

Insights from this research support more refined patient stratification, improved trial design, and the advancement of personalized medicine approaches. Understanding response variability helps ensure that clinical trials produce more precise and clinically meaningful results.